Health system expenditure 2023-2024 (AIHW)

In 2023-2024, the expenditure for asthma was an estimated $1.28 billion spent on the treatment and management of asthma (out of $180.4 billion total spending on disease and injury and $98 billion spent on chronic conditions, and $5.77 billion spent on respiratory disease in 2023-2024), making asthma the third most costly respiratory condition (after COPD and upper respiratory conditions).(ref 1)

This is an increase from $1,192 million in 2022-23 and $852 million in 2020-21 (ref 2, 3)

Asthma expenditure in 2023-24 included (ref1):

• $549 million spent on pharmaceuticals
• $210 million spent on GP
• $166 million spent on public hospital admissions
• $146 million spent on public hospital EDs
• $104 million spent on public hospital outpatient services

Spending on asthma by jurisdictions (ref 1):

• ACT: $25.04 million
• NSW: $402.83 million
• NT: $12.78 million
• QLD: $254.19 million
• SA: $94.56 million
• TAS: $31.84 million
• VIC: $335.08 million
• WA: $126.12 million